These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25842192)

  • 1. Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia.
    Ando T; Kojima K; Isoda H; Eguchi Y; Honda T; Ishigami M; Kimura S
    Int J Hematol; 2015 Sep; 102(3):379-82. PubMed ID: 25842192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy in patients with chronic myeloid leukemia: two cases report and literatures review].
    Wang YD; Cui GH; You Y; Li M; Xia J; Hu Y
    Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):743-6. PubMed ID: 23336229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Hepatitis B Reactivation Among Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors.
    Atteya A; Ahmad A; Daghstani D; Mushtaq K; Yassin MA
    Cancer Control; 2020; 27(1):1073274820976594. PubMed ID: 33297765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression.
    Lazarevic I; Banko A; Miljanovic D; Cupic M
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31450544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy.
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Tachi Y; Ishikawa T; Katano Y; Yoshioka K; Toyoda H; Kumada T; Goto H; Hirooka Y
    J Gastroenterol; 2016 Nov; 51(11):1081-1089. PubMed ID: 26943169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hepatic decompensation from hepatitis B virus reactivation in hematological malignancy treatments.
    Barone M
    World J Gastroenterol; 2024 Jul; 30(25):3147-3151. PubMed ID: 39006388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections in patients on BCR-ABL tyrosine kinase inhibitor therapy: cases and review of the literature.
    Knoll BM; Seiter K
    Infection; 2018 Jun; 46(3):409-418. PubMed ID: 29388066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of resolved hepatitis B virus infection with immune escape mutations after long-term corticosteroid therapy.
    Inoue J; Kondo Y; Wakui Y; Kogure T; Morosawa T; Fujisaka Y; Umetsu T; Takai S; Nakamura T; Shimosegawa T
    Clin J Gastroenterol; 2016 Apr; 9(2):93-8. PubMed ID: 26919858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus reactivation in a chronic myeloid leukemia patient treated with imatinib mesylate.
    Wang YD; Cui GH; Li M; Gowrea B; Xia J; Hu Y
    Chin Med J (Engl); 2012 Jul; 125(14):2636-7. PubMed ID: 22882953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of Resolved Hepatitis B virus Infection before the Relapse of Lymphoma : Immunosuppressive effect of the Lymphoproliferative disorders?
    Gokturk HS; Unler GK; Gokturk B
    Acta Gastroenterol Belg; 2016 Mar; 79(1):63-4. PubMed ID: 26852769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.
    Nakamoto S; Kanda T; Nakaseko C; Sakaida E; Ohwada C; Takeuchi M; Takeda Y; Mimura N; Iseki T; Wu S; Arai M; Imazeki F; Saito K; Shirasawa H; Yokosuka O
    Int J Mol Sci; 2014 Nov; 15(11):21455-67. PubMed ID: 25421241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.
    Salpini R; Colagrossi L; Bellocchi MC; Surdo M; Becker C; Alteri C; Aragri M; Ricciardi A; Armenia D; Pollicita M; Di Santo F; Carioti L; Louzoun Y; Mastroianni CM; Lichtner M; Paoloni M; Esposito M; D'Amore C; Marrone A; Marignani M; Sarrecchia C; Sarmati L; Andreoni M; Angelico M; Verheyen J; Perno CF; Svicher V
    Hepatology; 2015 Mar; 61(3):823-33. PubMed ID: 25418031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
    Hammond SP; Borchelt AM; Ukomadu C; Ho VT; Baden LR; Marty FM
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The difficulties of managing severe hepatitis B virus reactivation.
    Roche B; Samuel D
    Liver Int; 2011 Jan; 31 Suppl 1():104-10. PubMed ID: 21205146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
    Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
    J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Knöll A; Boehm S; Hahn J; Holler E; Jilg W
    J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
    Cho Y; Yu SJ; Cho EJ; Lee JH; Kim TM; Heo DS; Kim YJ; Yoon JH
    J Med Virol; 2016 Jun; 88(6):1010-7. PubMed ID: 26531242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape.
    Martel N; Cotte L; Trabaud MA; Trepo C; Zoulim F; Gomes SA; Kay A
    J Infect Dis; 2012 Jun; 205(11):1757-61. PubMed ID: 22459735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for and management of hepatitis B virus reactivation in patients treated with anti-B-cell therapy.
    Kusumoto S; Tobinai K
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):576-83. PubMed ID: 25696914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.